Revenue (¥ bn, bars) · net margin (%, line)
Source: securities reports
FY2006 · unconsolidated
Revenue$2.9B
Net income$122M
Net margin4.2%
→
FY2026 · consolidated
Revenue$3.7B
Net income$64M
Net margin1.8%
Inflators are not shipped far, so the 2000s were spent building them where cars are built: a US venture with Toyoda Gosei in 2000, Thailand in 2002, Poland in 2004, Jiangsu in China later the same year. A business that began as a spare use for gunpowder ended up embedded in the global assembly network, and through the 2010s it carried the group’s earnings while the older cellulose lines and the newer organic-synthesis and healthcare businesses steadied them.
The management problem then moved inside the fence. Under Ogawa Yoshimi, president from 2018 and an engineer from the production side, the Daicel production innovation developed at Aboshi was rolled out across the group: the intuition of veteran operators written out as hundreds of thousands of cases and pulled onto a single control screen, with IoT and AI optimizing the running of plants that had been steered by feel. In the same period Daicel bought out Celanese’s stake to make Polyplastics a wholly owned subsidiary, ending fifty-six years of joint control and consolidating the resin business under its own strategy, all inside the medium-term plan Accelerate 2025.
Sakaki Yasuhiro, an organic-synthesis researcher, took over in June 2024, keeping the production programme but pushing profit accountability down into strategic business units and concentrating R&D spending where the company is genuinely strong. The line of presidents — procurement, then production engineering, then research — reads as a list of the problems each decade thought most urgent. A hundred and six years on, the same two roots are still visible: cellulose, which became acetate, tow and display film, and propellant, which became the airbag.